Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SCY | Ann: Smiths City Group Limited ("SCY") - Delisting | 02/02/23 | 0 | 259 | |||
|
|||||||
SCY | Ann: EX SCGL LIMITED (FORMERLY SMITHS CITY GROUP LIMITED) (IN RE | 01/02/23 | 0 | 139 | |||
|
|||||||
SCY | Ann: RA: SCY: Smiths City enters receivership at Board's invitation | 22/05/20 | 0 | 373 | |||
|
|||||||
SCY | Ann: MKTUPDTE: SCY: Smiths City - Store Closures | 22/05/20 | 0 | 450 | |||
|
|||||||
SCY | Ann: TRANSACT: SCY: Conditions Update | 21/05/20 | 0 | 376 | |||
|
|||||||
SCY | Ann: TRANSACT: SCY: Smiths City Conditional Sale - Clarification | 20/05/20 | 0 | 360 | |||
|
|||||||
SCY | Ann: Smiths City Group Limited (“SCY”) – Suspension of quotation | 18/05/20 | 0 | 332 | |||
|
|||||||
SCY | Ann: Sale of Smiths City Business | 18/05/20 | 0 | 354 | |||
|
See All Discussions